Kenneth J. Kelley, Director at HALOZYME THERAPEUTICS INC (HTI), sold 500 shares at $8.37 ($4K) on 2007-03-27, disclosed to the SEC on 2007-03-28.
Scheduled sale ($4k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.36 | 300 | $3K | 59.9% |
| 2 | $8.37 | 100 | $837 | 20.0% |
| 3 | $8.45 | 100 | $845 | 20.2% |
| Total | $8.38 avg | 500 | $4K | 100% |
| Filing → |
| HALO | SELL | 2021-02-01 | $469K | — | Filing → |
| HALO | SELL | 2021-01-04 | $417K | — | Filing → |
| HALO | SELL | 2020-12-07 | $1.4M | — | Filing → |